SIMID First European Provider of Online Full Text Publications

SIMID International B.V.SIMID is the first in Europe to use a single centralized databank to bring scientific-medical full-text publications within easy reach. Through S.M.I.L.E. (Scientific Medical Information Library Europe), medical professionals can search for and download original publications and reviews online, from prominent international peer-reviewed medical scientific journals. Currently, the database contains more than 1000 journals from 28 internationally renowned publishers. S.M.I.L.E. is accessible through www.simid.org and is made possible in part by financial institutions and companies working in the healthcare industry, such as health insurance providers and the pharmaceutical industry.

Investment by the Health Innovation Fund
Recently the Health Innovation Fund I BV has joined SIMID as an investor. This fund is financed from Achmea, OPG, ABN/AMRO and TechnoPartner (the Dutch Ministry of Economic Affairs). "We are proud that this investor has provided us the opportunity to expand our unique product further. By informing medical professionals in Europe about the latest developments within their field, our clients can help them diagnose and treat patients more adequately," comments Boudewijn Gruwel, Director of Marketing & Sales of SIMID.

How does S.M.I.L.E. work?
The medical professional has a customized subscription allowing him free access to the information in S.M.I.L.E. This customized subscription is made possible in part by companies working in the healthcare industry, or financial institutions. "The subscriptions give companies the possibility to provide medical professionals access to the most recent and relevant scientific information," states Boudewijn Gruwel.

S.M.I.L.E. lets users read the latest publications, covering 43 different themes, such as oncology, surgery, cardiology, etc. Users can compile a personal profile and receive automatic alerts when relevant articles become available. The database can also be searched using individual keywords. S.M.I.L.E. is updated daily. The publications containing the listed titles are archived from 2000 on, and all articles can be downloaded as PDF files.

Who is S.M.I.L.E.'s target audience?
The S.M.I.L.E. online database is geared toward health professionals. These might be specialists or general practitioners, but might also be dentists, nurses, or physiotherapists.

About SIMID International B.V.
SIMID stands for the Scientific Institute for Medical Information and Documentation. The goal of SIMID is to provide access to scientific-medical information for health professionals by applying the one-stop-shopping principle. Offering complete publications on a single website creates a unique niche in services to medical professionals and the international healthcare-related industry. Through cooperation with international scientific publishers and the online database S.M.I.L.E., SIMID is the first and only company in Europe able to offer this service to medical professionals. SIMID has branches in the Netherlands and Switzerland. More information can be found at www.simid.org.

About the Health Innovation Fund I BV
The Health Innovation Fund I BV is a venture capital fund established in 2007. It focuses on innovative entrepreneurs providing technological, modernizing solutions and business models for the healthcare industry. Shareholders in this fund are ABN/AMRO, Achmea and OPG. The Health Innovation Fund I BV is administered by Residex, which uses specialized investment funds to offer opportunities to promising and ambitious players in the healthcare sector. More information is available at www.residex.nl.

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...